Johnson & Johnson-PENN
Proof of Concept Fund
Statement of Purpose
June 8 Deadline
The primary goal of the Johnson & Johnson
(J&J)-Penn Proof of Concept (PoC) Fund is to fund, on a University-wide
basis, early-stage Life Sciences research to achieve technological
“proof of concept”. Developed by Penn’s Office of
Strategic Initiatives (OSI) and Johnson & Johnson’s Corporate
Office of Science and Technology (COSAT), the Fund centers on development
of therapeutic areas and technology platforms of strategic interest
to J&J for potential product development opportunities in pharmaceuticals,
diagnostics, and medical devices. The purpose of this program is to
identify projects with potential for commercialization. Projects should
be at a developmental stage at which carefully designed studies are
likely to provide proof of concept. Awards from the Fund will be made
twice a year and will be administered by the Vice Provost for Research.
Areas of Interest
The PoC Fund supports the development of research for the following
- Cardiovascular Science
- Central Nervous System/Neurology
- Infectious Disease
The Fund also supports broadly the development of the following
- Drug Discovery Technologies
- Energy-Based Drugs Tissue Engineering
- Natural Products
- Nucleic Acid-Based Drugs
Funds must be spent within 12 months of the beginning of
the grant, and may not be “banked” for future use. Unexpended
funds must be returned.
Applications may request up to approximately $125,000 including
25% indirect costs.
Eligibility is limited to University of Pennsylvania faculty,
in any track, at any professorial level.
The Application should include:
- A Johnson & Johnson-Penn Proof of Concept Fund Proposal
Cover Sheet which can be downloaded
from the Website for the Fund (www.upenn.edu/research/poc).
- An abstract, no more than 200 words, written for the educated
- A description of the proposal, which should be no more than
5 single spaced pages. Proposals should provide background, purpose
and significance of the project, methods to be used, work to be
undertaken, and outlook for development.
- A single page biographical sketch for each investigator working
on the project.
- A budget with justification for each item requested. Items
that can be requested include salary for technical and trainee
staff, relevant travel, supplies, and minor equipment specifically
designed for the proposed research. These awards cannot be used
to support faculty salary.
- Other research support, including current funding with a list
of titles, amounts, sources, and grant periods, plus pending applications.
- Regulatory issues. If research involves human subjects, animals,
biohazards, or otherwise raises regulatory issues, the application
should identify those concerns and provide documentation that
they will be addressed. If IRB, IACUC, or Environmental Safety
review and approval is required, it may be obtained after the
proposal has been approved but must be in place before funds are
expended or research is initiated.
- Conflict of interest. The applicant should explicitly make
a statement whether or not the application involves any potential
conflict of interest and any such conflicts should be described
and appropriate financial disclosure submitted.
The complete proposal should be sent electronically as a
single PDF document to email@example.com
by June 8, 2005. Please notify Janine Corbett (215-898-3602) if
you have not received an electronic receipt for your proposal by
June 10, 2005.
There will be a two-phase review process.
- A Penn faculty-based Priority Committee, chaired by the Vice
Provost for Research, will prioritize applications on the basis
of merit, meeting unmet needs, and potential for future development
- A joint Penn-J&J Funding Committee will make the final
decision about funding.
Right and Commitments
- J&J will not have ownership rights to any funded research
results or related intellectual property.
- J&J will have the right of “First Disclosure”
to the Project Report (non-confidential description of research
results and potential future applications) of any funded research.
- J&J will receive an exclusive right to negotiate to fund
further technological development. Such right applies for 90 days,
after which right reverts to Penn for independent development.